BR vs EDIT
Broadridge Financial Solutions Inc (BR) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the BR and EDIT stock pages for the full models.
Not investment advice.